Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: ARQ-151 cream 0.05%;   Drug: ARQ-151 cream 0.15%;   Drug: ARQ-151 cream Vehicle Sponsor:   Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials